252 related articles for article (PubMed ID: 26528829)
41. Safety and immunogenicity of a measles-mumps-rubella-varicella vaccine given as a second dose in children up to six years of age.
Halperin SA; Ferrera G; Scheifele D; Predy G; Stella G; Cuccia M; Douha M; Willems P
Vaccine; 2009 May; 27(20):2701-6. PubMed ID: 19428882
[TBL] [Abstract][Full Text] [Related]
42. A New Combined Vaccine Against Measles, Mumps, Rubella and Varicella in India.
Shah N; Parikh R; Casabona G; Kolhapure S
Indian Pediatr; 2017 Dec; 54(12):1041-1046. PubMed ID: 29317560
[TBL] [Abstract][Full Text] [Related]
43. Risk of febrile seizures after first dose of measles-mumps-rubella-varicella vaccine: a population-based cohort study.
MacDonald SE; Dover DC; Simmonds KA; Svenson LW
CMAJ; 2014 Aug; 186(11):824-9. PubMed ID: 24914115
[TBL] [Abstract][Full Text] [Related]
44. Impact of history of febrile convulsions on the risk difference of febrile convulsions with the tetravalent measles-mumps-rubella-varicella vaccine: Post-hoc exploratory analysis of results from a matched-cohort study.
Gvozdenovic E; Vetter V; Willame C; Rosillon D
Vaccine; 2018 Sep; 36(39):5803-5806. PubMed ID: 30131195
[TBL] [Abstract][Full Text] [Related]
45. Immunogenicity and safety of measles-mumps-rubella, varicella and Haemophilus influenzae type b vaccines administered concurrently with a fourth dose of heptavalent pneumococcal conjugate vaccine compared with the vaccines administered without heptavalent pneumococcal conjugate vaccine.
Black SB; Cimino CO; Hansen J; Lewis E; Ray P; Corsaro B; Graepel J; Laufer D
Pediatr Infect Dis J; 2006 Apr; 25(4):306-11. PubMed ID: 16567981
[TBL] [Abstract][Full Text] [Related]
46. Immunogenicity and safety of intramuscular versus subcutaneous administration of a combined measles, mumps, rubella, and varicella vaccine to children 12 to 18 months of age.
Haas H; Richard P; Eymin C; Fiquet A; Kuter B; Soubeyrand B
Hum Vaccin Immunother; 2019; 15(4):778-785. PubMed ID: 30481110
[TBL] [Abstract][Full Text] [Related]
47. Evaluation of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Shinefield H; Black S; Digilio L; Reisinger K; Blatter M; Gress JO; Brown ML; Eves KA; Klopfer SO; Schödel F; Kuter BJ
Pediatr Infect Dis J; 2005 Aug; 24(8):665-9. PubMed ID: 16094217
[TBL] [Abstract][Full Text] [Related]
48. Measles-containing vaccines and febrile seizures in children age 4 to 6 years.
Klein NP; Lewis E; Baxter R; Weintraub E; Glanz J; Naleway A; Jackson LA; Nordin J; Lieu T; Belongia EA; Fireman B
Pediatrics; 2012 May; 129(5):809-14. PubMed ID: 22473362
[TBL] [Abstract][Full Text] [Related]
49. Second dose of measles-mumps-rubella-varicella vaccine (MMRV) and the risk of febrile convulsions.
Schäfer W; Reinders T; Schink T
Vaccine; 2022 Mar; 40(14):2168-2172. PubMed ID: 35232594
[TBL] [Abstract][Full Text] [Related]
50. Observational safety study of febrile convulsion following first dose MMRV vaccination in a managed care setting.
Jacobsen SJ; Ackerson BK; Sy LS; Tran TN; Jones TL; Yao JF; Xie F; Cheetham TC; Saddier P
Vaccine; 2009 Jul; 27(34):4656-61. PubMed ID: 19520201
[TBL] [Abstract][Full Text] [Related]
51. Adverse Events After MMR or MMRV Vaccine in Infants Under Nine Months Old.
Woo EJ; Winiecki SK; Arya D; Beeler J
Pediatr Infect Dis J; 2016 Aug; 35(8):e253-7. PubMed ID: 27167117
[TBL] [Abstract][Full Text] [Related]
52. The weight of MMRV-related febrile convulsions among other clinical factors contributing to febrile convulsions in children.
Gavrielov-Yusim N; Hoshen M; Singer SR; Neumann L; Balicer RD
Vaccine; 2014 Sep; 32(39):4954-9. PubMed ID: 25075803
[TBL] [Abstract][Full Text] [Related]
53. Policy statement—Prevention of varicella: update of recommendations for use of quadrivalent and monovalent varicella vaccines in children.
Committee on Infectious Diseases
Pediatrics; 2011 Sep; 128(3):630-2. PubMed ID: 21873692
[TBL] [Abstract][Full Text] [Related]
54. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
55. Similar relative risks of seizures following measles containing vaccination in children born preterm compared to full-term without previous seizures or seizure-related disorders.
McClure DL; Jacobsen SJ; Klein NP; Naleway AL; Kharbanda EO; Glanz JM; Jackson LA; Weintraub ES; McLean HQ
Vaccine; 2019 Jan; 37(1):76-79. PubMed ID: 30478005
[TBL] [Abstract][Full Text] [Related]
56. Safety and immunogenicity of a measles, mumps, rubella and varicella vaccine given with combined Haemophilus influenzae type b conjugate/hepatitis B vaccines and combined diphtheria-tetanus-acellular pertussis vaccines.
Shinefield H; Black S; Thear M; Coury D; Reisinger K; Rothstein E; Xu J; Hartzel J; Evans B; Digilio L; Schödel F; Brown ML; Kuter B;
Pediatr Infect Dis J; 2006 Apr; 25(4):287-92. PubMed ID: 16567978
[TBL] [Abstract][Full Text] [Related]
57. Dose-response study of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children.
Shinefield H; Black S; Williams WR; Marchant C; Reisinger K; Stewart T; Meissner HC; Guerrero J; Klopfer SO; Xu J; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2005 Aug; 24(8):670-5. PubMed ID: 16094218
[TBL] [Abstract][Full Text] [Related]
58. Immunogenicity and safety of a combined measles, mumps, rubella and varicella live vaccine (ProQuad ®) administered concomitantly with a booster dose of a hexavalent vaccine in 12-23-month-old infants.
Deichmann KA; Ferrera G; Tran C; Thomas S; Eymin C; Baudin M
Vaccine; 2015 May; 33(20):2379-86. PubMed ID: 25765966
[TBL] [Abstract][Full Text] [Related]
59. Simultaneous vaccination of Chinese applicants for a United States immigrant visa.
Hua L; Hongtao H; Shunqin W; Jinping G; Jiandong C; Zhaoliang L; Xinwen F
Travel Med Infect Dis; 2008 May; 6(3):130-6. PubMed ID: 18486068
[TBL] [Abstract][Full Text] [Related]
60. Impact of MMRV combination vaccine on childhood vaccination compliance.
Ackerson BK; Sy LS; Yao JF; Cheetham CT; Jacobsen SJ
Am J Manag Care; 2012 Dec; 18(12):e440-5. PubMed ID: 23286673
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
